Finzati - Logo
PEN logo

Penumbra, Inc.

PEN • Medical - Devices
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$12.78B
Growth
21.1%
Cash Flow
3/5
Trend
Mostly stable
Evidence
Stable or improving margins · 12.7%Positive revenue growth · 15.4%Positive free cash flow · 4.49Manageable debt level · 0.15Healthy liquidity · 6.64
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 1:37 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$12.78B
52W Range221.26 - 362.41
Beta0.70
Gross Margin67.14%
Oper. Margin13.48%
Profit Margin12.66%
Debt/Eq0.15
Current Ratio6.64
Quick Ratio4.29
Revenue 5Y21.13%

Investment DNA

How strong this company looks for long-term investors

71
out of 100
Business Quality
Margins, moat, returns
74/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
25/100
Why this score▼
Stable or improving margins · 12.7%Positive revenue growth · 15.4%Positive free cash flow · 4.49Manageable debt level · 0.15Healthy liquidity · 6.64Expensive earnings multiple · 68.1

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-06
Low
$320.00
Mean
$347.00
Median
$347.00
High
$374.00

Company Overview

IPO: 9/18/2015
Industry: Medical - Devices
P/B i: 8.48
Debt / Equity i: 0.15
Operating Margin: 13.48%
Net Margin: 12.66%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.15
Current Ratio: 6.64
Quick Ratio: 4.29
Status: Good

Insider Transactions

Recent executive and insider activity

Elsesser Adam
Transaction: 05/19/2026
SELL
Change
-77,000
Price
Not reported
Filing
05/21/2026
Type
SELL
Grewal Harpreet
Transaction: 04/02/2026
SELL
Change
-100
Price
$328.22
Filing
04/06/2026
Type
SELL
Shiu Lambert
Transaction: 03/15/2026
SELL
Change
-150
Price
$336.18
Filing
03/17/2026
Type
SELL